Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sulfasalazine neurotoxicity].

M L Chadenat1, S Morelon, C Dupont

  • 1Service de Médecine Interne 2 (Pr Rouveix), Hôpital Ambroise-Paré, 9, avenue Charles-de-Gaulle, 92104 Boulogne Cedex. marie-laurie.chadenat@apr.ap-hop-paris.fr

Annales De Medecine Interne
|July 28, 2001
PubMed
Summary

Sulfasalazine, a medication for polyarthritis, can rarely cause severe neurotoxicity, including seizures and acute encephalopathy. This case highlights a seldom-reported adverse effect of this common drug.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Embryotoxicity testing of IVF disposables: how do manufacturers test?

Human reproduction (Oxford, England)·2020
Same author

[How to promote hospital teams to users for their involvement in the actions of the perinatal networks?]

Gynecologie, obstetrique, fertilite & senologie·2019
Same author

Recurrence of a primary xanthoma of the humerus in a 9-year-old normolipidemic child.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2019
Same author

Nutritional risks of ARFID (avoidant restrictive food intake disorders) and related behavior.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2019
Same author

[Polycystic ovary syndrome does not affect blastulation nor cumulative live birth rates].

Gynecologie, obstetrique, fertilite & senologie·2019
Same author

[Overview of induction of labor practices in France].

Gynecologie, obstetrique, fertilite & senologie·2019

Area of Science:

  • Neurology
  • Rheumatology
  • Clinical Pharmacology

Background:

  • Sulfasalazine is a widely used disease-modifying antirheumatic drug (DMARD) for various inflammatory conditions, including polyarthritis.
  • While generally well-tolerated, sulfasalazine has been associated with a range of adverse effects, predominantly gastrointestinal and dermatological.
  • Neurological side effects are uncommon but have been documented.

Observation:

  • A female patient undergoing treatment for polyarthritis with sulfasalazine developed new-onset seizures and acute encephalopathy.
  • The patient's neurological symptoms emerged during the course of sulfasalazine therapy.
  • Other potential causes for the neurological presentation were considered and ruled out.

Findings:

  • The clinical presentation strongly suggested sulfasalazine-induced neurotoxicity.

Related Experiment Videos

  • This represents a rare but serious adverse reaction to sulfasalazine.
  • The case underscores the importance of considering drug-induced neurotoxicity in patients presenting with unexplained neurological symptoms.

    • Implications:

    • Clinicians should maintain a high index of suspicion for sulfasalazine neurotoxicity in patients with polyarthritis who develop neurological symptoms.
    • Early recognition and discontinuation of sulfasalazine may be crucial for favorable outcomes.
    • Further research into the mechanisms and risk factors for sulfasalazine neurotoxicity is warranted.